Posts Tagged ‘Supports’

Genedata Screener Now Supports Streamlined Collaboration among Pharmas and CROs

Basel, Switzerland (PRWEB) May 12, 2015

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that the Genedata Screener® platform supports data- and result-sharing with Contract Research Organizations (CROs). Genedata Screener provides a framework for systematic import, processing, and end-result propagation for all types of screening experiments, making it ideal for different collaboration models and partner ecosystems among pharmaceutical companies and CROs. As used by Roche, Genedata Screener is a comprehensive software solution supporting global operations, leveraged as a collaboration platform to help expedite drug discovery, reduce data analysis costs, and lower overhead for pharmaceutical R&D.

Web-based and cloud-compatible, Genedata Screener can be used as a data analysis and exchange platform. Installed at a CRO site, on-site or in the cloud, it enables a pharma’s CRO partner to easily exchange data with the pharma’s Screener instance. The system’s inherent business logic allows pharmas to maintain consistent workflows with their company-specific business rules for results regardless of the CRO doing the analysis.

Secure and Consistent Platform for Collaborative Research Lowers Total Cost of Ownership

Pharmaceutical companies – both large and small – are using collaborative research to help replenish therapeutic pipelines and advance innovation. Such collaborative research models provide access to specific technologies, streamline operations, lower costs, and accelerate drug discovery. Outsourcing screening and the corresponding data analysis to CROs is a valuable research model and business strategy for many leading pharmaceutical companies. This model increases flexibility for drug discovery and draws from a broader expertise for improved results.

Successful collaborative research with external partners requires all parties to have complete insight into the data produced by an experiment, the data analysis methods applied, and the rationale for decision making (e.g. specific artifact corrections or decisions on hit calling and compound progression). Having both in-house and external researchers using the same consistent methodology and standardized processing of results is critical for maintaining research integrity. Genedata Screener creates a framework for a successful collaboration paradigm as it provides a platform for sharing business rules and analysis methodologies as well as strict control of access, (re-)analysis, and modification permissions. Furthermore, all steps and modifications are tracked along the process, yielding a full audit trail across different functions and organizations.

Enabling CROs to collaborate with in-house scientists, Genedata Screener not only extends the lab bench, it also supports a variety of collaboration models (i.e. multi-sided and peer-to-peer). It helps pharmaceutical companies go beyond commodity screening with end-to-end data sharing and analysis, which can transfer raw data and results between two instances of Screener. Additional platform features include:

Automated Data Exchange for long-term collaboration spanning several projects. Results are synchronized through different Genedata Screener instances to easily collect and centralize project data and compound results.
IP Protection as the collaboration server is a Genedata Screener instance that requires precise definition of project access and information content per project.
Large Dataset Analysis – even in the cloud – to enable cost-effective and streamlined management and delivery of data analysis.

“Genedata Screener, used as a modern collaboration platform, continues to support evolving R&D needs without organizations making additional technology investments,” noted Dr. Othmar Pfannes, CEO of Genedata. “And, the beauty of this industry-leading low TCO is that it also accelerates the pace of novel drug discovery.”

About Genedata

Genedata transforms data into intelligence with a portfolio of advanced software solutions, which make research data accessible and understandable and research processes more efficient. These solutions are used worldwide by leading pharmaceutical, industrial, and agricultural biotechnology companies as well as academic research organizations. Genedata innovations enable scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Germany, Japan, and the US. Follow Us on LinkedIn.

Vocus©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Related Small Business Press Releases

Prospero Foundation Supports a Farmer in Honduras

Antibes, France (PRWEB) October 16, 2014

The Prospero Foundation, founded by Ulrik DeBo of DeBondo Capital, is excited to announce that a microloan donation has been made to Juan, a farmer in the town of Azacualpa, Santa Bárbara in Honduras

Juan is 43 and married, with two children. He has worked in agriculture his whole life, growing various crops. His principal crop that affords him his main source of income, however, is coffee, which he sells in the local market. He intends to use these funds to buy fungicide, manure, pesticide and other supplies to help ensure a bigger harvest. His goal is to improve his family’s living conditions.

About Micro-lending with The Prospero Foundation

Through partnerships with local lending institutions, the Prospero Foundation contributes capital for the purpose of small business loans to these micro-entrepreneurs in developing nations. Through these partnerships, the Foundation helps small business people such as farmers, shopkeepers, and artisans build their businesses and in turn stimulate economic development in their communities. This loan is administered by Organización de Desarrollo Empresarial Femenino Financiera, S.A. (ODEF). A leader in the microfinance sector for nearly thirty years, ODEF strives to combat poverty by offering a wide array of financial services to the low-income sector. The organisation works with its parent NGO, ODEF OPD, to provide training and technical assistance to impoverished microentrepreneurs. By incorporating the entire family unit in this process, ODEF OPD aims to improve the standard of living through the creation of profitable enterprises.

About The Prospero Foundation

The Prospero Foundation is a private, international charitable foundation founded by Ulrik DeBo. Mr DeBo, a lifelong entrepreneur, whose upbringing and eventual success in the finance industry, through his company DeBondo Capital Ltd, gave him the relevant experience and insight required.


The foundation is run by a global network of entrepreneurs, who raise funds privately amongst their business contacts, and choose to invest them using a ‘pay-it-forward’ philosophy to focus on charitable projects that promise to perpetuate a chain reaction of positive growth opportunities for individuals and local communities for generations to come.


It is a foundation that empowers citizens to help themselves and those around them.


For additional information, please visit

Contact Address:

Prospero EnFrance (Registration No: W061004154)


Vocus©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

More International Business Press Releases

IIUSA Supports Inter-Agency Collaboration to Protect the Integrity of the EB-5 Program


Chicago, IL (PRWEB) October 03, 2013

The Association to Invest In the USA (IIUSA), the trade association representing more than 100 EB-5 Regional Centers, supports the recent action of the U.S. Securities and Exchange Commission (SEC) to stop a Regional Center in Texas from allegedly defrauding EB-5 investors. IIUSA also applauds the U.S. Citizenship and Immigration Services (USCIS) for its cooperation with the SEC in the matter.

“Proper oversight, transparency, compliance with – and enforcement of – all applicable securities, anti-fraud and immigration laws and regulations are essential to maintain the confidence of all industry stakeholders and ensure that the EB-5 program continues to bring capital and job creation to American communities,” said Peter D. Joseph, Executive Director of IIUSA.

“Our position is clear: efficient and effective enforcement of U.S. securities laws is as essential for the EB-5 program as it is for any investment vehicle,” said K. David Andersson, President of IIUSA.

The EB-5 Regional Center economic development program successfully spurs U.S. job creation and economic growth by attracting foreign direct investment in the United States. A comprehensive peer-reviewed economic study found that from 2010-2011, investments made through the EB-5 program contributed $ 2.2 billion to U.S. GDP and supported over 28,000 jobs at no cost to taxpayers. IIUSA’s members account for 95 percent of all capital raised through the EB-5 program.

IIUSA has a track record of working cooperatively with USCIS and other regulatory agencies to strengthen the program through effective enforcement of anti-fraud, securities and immigration law. For example, IIUSA recently filed an amicus brief supporting SEC action to stop a Regional Center and developer from making misleading claims about investment opportunities.

Other initiatives supported by IIUSA include:

An “Investor Alert” jointly issued by the SEC and USCIS that provides prospective EB-5 investors with information on conducting due diligence evaluations of EB-5 securities offerings.

Distribution of guidance published by FINRA for broker-dealers marketing EB-5 related securities.

Support for several important reforms included in the comprehensive immigration reform legislation that recently passed the full Senate that would strengthen law enforcement and national security protections.

“Investments made through EB-5 Regional Centers provide a new, vital source of funding for local economic development projects, often in partnership with local governments and economic development agencies. These successful projects are revitalizing communities across the country, creating and supporting jobs, infrastructure and services,” noted Joseph. “Protecting the integrity of the program is critical to continue bringing jobs and economic benefits to cities and towns across the country.”


Founded in 2005, the Association to Invest In the USA (IIUSA) is the national not-for-profit industry trade association for the EB-5 Regional Center Program, representing well over 100 Regional Center members that account for over 95 percent of the capital flowing through the Program. IIUSA represents the industry in government and public affairs, telling the story of how the EB-5 Program has become a fundamental part of U.S. economic development policy – with operations covering advocacy, industry development, and education. An essential part of IIUSA’s mission is to stimulate economic development and job growth through continued success of the program as well as advance and maintain industry standards and best practices.

Follow us on:

Contact's Google Plus

Vocus©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.